https://www.marketscreener.com/quote/stock/RYVU-THERAPEUTICS-S-A-19156501/news/Ryvu-Therapeutics-S-A-Announces-First-Patient-Dosed-in-Phase-I-II-Study-of-RVU120-in-Patients-with-36254262/?utm_source=telegram&utm_medium=social&utm_campaign=share